The "Ophthalmology Journal" is a peer-reviewed, comprehensive journal on ophthalmology, created by German and Polish experts in the field, directed to the international community of authors, intending to impulse further development of this area of clinical medicine. 

The Journal welcomes submissions in English of original research reporting clinical observations and laboratory investigations with clinical relevance. Editors will also accept case reports, up to date reviews, editorials, education articles, letters and other relevant manuscripts that relate to the sense of sight, especially these describing new diagnostic and surgical techniques, also instrument and therapy updates. Manuscripts covering regional issues should also address a global context.

Review process and manuscript selection
″Ophthalmology Journal″ is committed to prompt evaluation and publication of submitted articles. All manuscripts together with supplementary files should be submitted online at www.cardiologyjournal.org. The submission and review process is fully electronic and submissions by e-mail or postal mail will not be accepted. Please follow the manuscript preparation directions presented below. Manuscripts submitted for publication in OJ are evaluated as to whether they present new insights into the announced topic and are likely to contribute to progress in research or to changes in clinical practice. Received manuscripts are initially examined by the Journal editors. Manuscripts with insufficient priority for publication are rejected immediately to allow the authors to recognize deficiencies and submit the paper to another journal or submit a revised version to OJ. Incomplete submissions or manuscripts not prepared in the required style (see ′Preparation of manuscripts′) are sent back to the authors without scientific review. If manuscript is accepted for review, the authors will be notified in the electronic way only with the reference to the article ID number in the electronic system. Articles are evaluated by at least two outside referees who are contacted before being sent a paper and asked to return comments within 3 weeks. All submitted manuscripts are treated as confidential documents, and reviewers are instructed to treat manuscripts as such. The peer review process is also confidential and identities of reviewers are not released. Referees are asked to provide a written review together with recommendation of acceptance, requirement for revision or rejection of the article. Submitted papers are accepted for publication after a positive opinion has been returned by the referees. Authors are notified of decisions by e-mail only. Selected papers are edited to improve accuracy and clarity and for length. Papers submitted to OJ but not accepted for publication may, in some cases, be eligible for publication in other journals of the Publisher.

Manuscripts authored by Editors or members of Editorial Board are treated no differently to any other manuscript submitted to Ophthalmology Journal (OJ). All possible measures are undertaken to avoid any potential conflict of interest in handling of such manuscripts at all the stages including allocation of handling Editor, selection of reviewers, decision making and, if required, processing for publication.

Editors or Editorial Board members may submit their own manuscripts for possible publication in OJ occasionally, but they are completely excluded from peer–review process and publication decisions when they are authors or co–authors of a manuscript. Manuscripts authored by a member of a journal’s editorial team (editors, Editorial Board members) are independently peer–reviewed and the peer review process is managed by the alternative members of the Editorial Board.

Reviewers’ criteria for manuscripts qualification

Title reflects the subject undertaken
Assumptions are proper
Work of practical nature
Work of educational nature
Aims are clearly defined
Appropriate methodology*
Ethical criteria fulfilled*
Research-based work*
Results are adequately presented*
Statistical analysis is reliable*
Discussion refers to results*
Conclusions based on study findings*
Conclusions refer to aims*
Suitably chosen, proper number and up to date references
Proper length
All figures and tables are required
Standard of written English acceptable 

*criteria exclusively for research papers 

Manuscripts authored by Editors or members of Editorial Board are treated no differently to any other manuscript submitted to Ophthalmology Journal. All possible measures are undertaken to avoid any potential conflict of interest in handling of such manuscripts at all the stages including allocation of handling Editor, selection of reviewers, decision making and, if required, processing for publication.

Editors or Editorial Board members may submit their own manuscripts for possible publication in The Journal occasionally, but they are completely excluded from peer–review process and publication decisions when they are authors or co–authors of a manuscript. Manuscripts authored by a member of a journal’s editorial team (editors, Editorial Board members) are independently peer–reviewed and the peer review process is managed by the alternative members of the Editorial Board.

Articles published on-line in the Journal are available in open access immediately after publication and are published under Creative Common Attribution-Non Commercial-No Derivatives 4.0 International (CC BY-NC-ND 4.0) allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially.

Via Medica (Publisher) self-archiving policy establishes that authors can archive only accepted manuscripts including final PDF version and/or  'ahead of print' in any repository. In details, the author may only post their version provided acknowledgment is given to the original source of publication and a link is inserted to the published article on Via Medica (Publisher) website. Apart from the link mentioned above, the acknowledgment should be provided with the full bibliographic record with DOI number.

Ophthalmology Journal (OJ) will accept advertising for services and products that are of value to readers in their professions. Distinction between advertising and editorial content should be easy. OJ does not allow advertising to influence editorial decisions. Online advertising or sponsorship should not impede users’ access to editorial content. Journal accepts advertising from competitors. Advertisements or sponsorship related to tobacco products will not be accepted.

Advertisements and sponsorship must be legal, trusthworthy and comply with the relevant industry codes, laws and regulations.

This policy applies to complaints on policies, procedures and actions of OJ’s editorial staff and as a rule is regarded as an opportunity for improvement. Complaints will be dealt with by members of the editorial staff, escalating (if required) to editor-in-chief, whose decision is regarded as final. Complaints should be directly emailed to a person indicated as a support contact at the Journal’s contact panel.  All complaints will be acknowledged within three working days and, if possible, a full response will be made within three weeks. If this is not possible an interim response will be given within this timeframe. Further responses will be provided until the issue is resolved.

If authors are convinced that the article they submitted was rejected wrongly, they should send rebuttal letter via OJ’s support contact rather than submitting a revised article at this stage. If the editors agree to such appeal, authors may be asked to submit a revised version of the article in question which will enter again into OJ’s review process. The rebuttal letter should be detailed and include responses to comments from external reviewers and from Journal’s editors. Only one appeal per article will be considered. An invitation for resubmission after appealing is by itself not a guarantee of acceptance.

To secure release from the responsibilities to the third parties, corresponding author is required to return to the Publisher a singed copy of the ‘Authors' statement (additionally to Cover Letter) together with the manuscript (the Authors' statement form is available at the end Author Guidelines section). All authors must agree to the conditions of publication, however the final responsibility for this information lays on the author submitting the manuscript.

This publication is intended for doctors and students of medicine. Every effort has been made to provide actual information, especially on medicine dosage, however, it is advisable that doctors make final decisions on their usage. This publication is not meant to replace a proper medical diagnosis or therapy. Responsibility taken by authors is suitable for this kind of publication and is not tantamount to responsibility for an individual medical advice.

The publisher has made every effort concerning reliability of the publication and the included information on the assortment, medicines and their prices. Yet the only legal information valid in the Republic of Poland are legal acts and in terms of trade – price offers of drugstores. As far as the information on medicines is concerned, the only lawful information is an updated characteristic of a medicinal substance and its producer’s leaflet.

The authors, consultants and publishers of this publication do not take any responsibility for possible mistakes or harms resulted from the information usage. Any cases of legal claims connected with medicines and chemical substances being under clinical examination are not going to be taken into consideration.

The Journal encourages you to share data that supports your research publication where appropriate. Research data refers to the results of observations or experimentation that validate research findings. If you are sharing data, you are encouraged to cite the data in your manuscript and reference list.

If you have made your research data available in a data repository, you can link your article directly to the dataset thus giving readers access to underlying data that gives them a better understanding of the research described. There are different ways to link your datasets to your article. When available, you can directly link your dataset to your article by providing the relevant information in the submission system. 

 Via Medica recommends the use of Mendeley Data, which enables you to deposit any research data (including raw and processed data, video, code, software, algorithms, protocols, and methods) associated with your manuscript in a free-to-use, open access repository. 

This publication is intended for doctors and students of medicine. Every effort has been made to provide actual information, especially on medicine dosage, however, it is advisable that doctors make final decisions on their usage. This publication is not meant to replace a proper medical diagnosis or therapy. Responsibility taken by authors is suitable for this kind of publication and is not tantamount to responsibility for an individual medical advice.

The publisher has made every effort concerning reliability of the publication and the included information on the assortment, medicines and their prices. Yet the only legal information valid in the Republic of Poland are legal acts and in terms of trade – price offers of drugstores. As far as the information on medicines is concerned, the only lawful information is an updated characteristic of a medicinal substance and its producer’s leaflet.

The authors, consultants and publishers of this publication do not take any responsibility for possible mistakes or harms resulted from the information usage. Any cases of legal claims connected with medicines and chemical substances being under clinical examination are not going to be taken into consideration.